vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Palladyne AI Corp. (PDYN). Click either name above to swap in a different company.

DBV Technologies S.A. is the larger business by last-quarter revenue ($2.8M vs $1.7M, roughly 1.7× Palladyne AI Corp.). Palladyne AI Corp. runs the higher net margin — -89.9% vs -1195.5%, a 1105.6% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 118.3%). Palladyne AI Corp. produced more free cash flow last quarter ($-8.7M vs $-32.6M). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -30.5%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Palladyne AI Corp. is an American company known for most of its existence primarily as a developer of robots. Palladyne was founded in 1983 as Sarcos Research Corporation. In 2023, Sarcos shifted its business focus to the development of artificial intelligence (AI) software for robotic applications, discontinuing its hardware operations. In March 2024, the company changed its name to Palladyne AI.

DBVT vs PDYN — Head-to-Head

Bigger by revenue
DBVT
DBVT
1.7× larger
DBVT
$2.8M
$1.7M
PDYN
Growing faster (revenue YoY)
DBVT
DBVT
+40.5% gap
DBVT
158.8%
118.3%
PDYN
Higher net margin
PDYN
PDYN
1105.6% more per $
PDYN
-89.9%
-1195.5%
DBVT
More free cash flow
PDYN
PDYN
$23.8M more FCF
PDYN
$-8.7M
$-32.6M
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-30.5%
PDYN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
PDYN
PDYN
Revenue
$2.8M
$1.7M
Net Profit
$-33.2M
$-1.5M
Gross Margin
15.6%
Operating Margin
-1235.7%
-560.7%
Net Margin
-1195.5%
-89.9%
Revenue YoY
158.8%
118.3%
Net Profit YoY
-8.9%
97.2%
EPS (diluted)
$-0.24
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
PDYN
PDYN
Q4 25
$1.7M
Q3 25
$2.8M
$860.0K
Q2 25
$1.5M
$1.0M
Q1 25
$1.7M
Q4 24
$761.0K
Q3 24
$871.0K
Q2 24
$1.2M
$2.7M
Q1 24
$1.4M
$3.4M
Net Profit
DBVT
DBVT
PDYN
PDYN
Q4 25
$-1.5M
Q3 25
$-33.2M
$-3.7M
Q2 25
$-41.9M
$-7.5M
Q1 25
$22.8M
Q4 24
Q3 24
$-7.1M
Q2 24
$-33.1M
$-5.3M
Q1 24
$-27.3M
$-7.2M
Gross Margin
DBVT
DBVT
PDYN
PDYN
Q4 25
15.6%
Q3 25
46.4%
Q2 25
53.3%
Q1 25
79.4%
Q4 24
27.2%
Q3 24
45.0%
Q2 24
79.0%
Q1 24
45.2%
Operating Margin
DBVT
DBVT
PDYN
PDYN
Q4 25
-560.7%
Q3 25
-1235.7%
-937.8%
Q2 25
-2806.2%
-797.4%
Q1 25
-405.3%
Q4 24
Q3 24
-838.0%
Q2 24
-2914.9%
-213.3%
Q1 24
-2029.7%
-213.7%
Net Margin
DBVT
DBVT
PDYN
PDYN
Q4 25
-89.9%
Q3 25
-1195.5%
-434.9%
Q2 25
-2858.4%
-737.6%
Q1 25
1330.9%
Q4 24
Q3 24
-814.7%
Q2 24
-2852.4%
-196.2%
Q1 24
-1943.5%
-210.1%
EPS (diluted)
DBVT
DBVT
PDYN
PDYN
Q4 25
$-0.02
Q3 25
$-0.24
$-0.09
Q2 25
$-0.31
$-0.20
Q1 25
$0.55
Q4 24
Q3 24
$-0.27
Q2 24
$-0.34
$-0.20
Q1 24
$-0.28
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
PDYN
PDYN
Cash + ST InvestmentsLiquidity on hand
$69.8M
$47.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$74.7M
Total Assets
$110.5M
$95.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
PDYN
PDYN
Q4 25
$47.1M
Q3 25
$69.8M
$57.1M
Q2 25
$103.2M
$62.7M
Q1 25
$46.6M
Q4 24
$40.1M
Q3 24
$21.3M
Q2 24
$66.2M
$25.8M
Q1 24
$101.5M
$31.8M
Stockholders' Equity
DBVT
DBVT
PDYN
PDYN
Q4 25
$74.7M
Q3 25
$52.9M
$51.8M
Q2 25
$86.2M
$53.8M
Q1 25
$28.3M
Q4 24
$-9.5M
Q3 24
$23.4M
Q2 24
$79.1M
$29.8M
Q1 24
$111.7M
$34.2M
Total Assets
DBVT
DBVT
PDYN
PDYN
Q4 25
$95.7M
Q3 25
$110.5M
$72.9M
Q2 25
$143.4M
$78.3M
Q1 25
$63.3M
Q4 24
$56.3M
Q3 24
$38.7M
Q2 24
$114.2M
$45.1M
Q1 24
$145.9M
$50.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
PDYN
PDYN
Operating Cash FlowLast quarter
$-32.4M
$-8.5M
Free Cash FlowOCF − Capex
$-32.6M
$-8.7M
FCF MarginFCF / Revenue
-1173.5%
-526.2%
Capex IntensityCapex / Revenue
4.2%
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
PDYN
PDYN
Q4 25
$-8.5M
Q3 25
$-32.4M
$-6.3M
Q2 25
$-33.9M
$-5.3M
Q1 25
$-7.5M
Q4 24
$-22.6M
Q3 24
$-4.5M
Q2 24
$-35.1M
$-5.8M
Q1 24
$-34.7M
$-7.2M
Free Cash Flow
DBVT
DBVT
PDYN
PDYN
Q4 25
$-8.7M
Q3 25
$-32.6M
$-6.7M
Q2 25
$-33.9M
Q1 25
$-7.6M
Q4 24
$-22.9M
Q3 24
$-4.5M
Q2 24
$-35.8M
$-5.9M
Q1 24
$-36.0M
$-7.3M
FCF Margin
DBVT
DBVT
PDYN
PDYN
Q4 25
-526.2%
Q3 25
-1173.5%
-776.0%
Q2 25
-2316.5%
Q1 25
-445.0%
Q4 24
-3008.1%
Q3 24
-517.8%
Q2 24
-3084.0%
-218.9%
Q1 24
-2560.6%
-212.1%
Capex Intensity
DBVT
DBVT
PDYN
PDYN
Q4 25
14.2%
Q3 25
4.2%
44.7%
Q2 25
2.2%
0.0%
Q1 25
5.4%
Q4 24
34.8%
Q3 24
1.4%
Q2 24
63.0%
5.3%
Q1 24
94.9%
1.8%
Cash Conversion
DBVT
DBVT
PDYN
PDYN
Q4 25
Q3 25
Q2 25
Q1 25
-0.33×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons